Clinical Trials Directory

Trials / Unknown

UnknownNCT03994029

Effect of Polyphenol Supplementation on Hepatic Steatosis and Vascular Compliance

The Effects of Polyphenol Supplementation on Hepatic Steatosis, Intima-media Thickness and Non-invasive Vascular Elastography in Obese Adolescents

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
St. Justine's Hospital · Academic / Other
Sex
All
Age
12 Years – 18 Years
Healthy volunteers
Not accepted

Summary

The main objective is to study the effect of polyphenol supplementation on hepatic steatosis as measured by hepatic ultrasound, hepatic magnetic resonance imaging and on intima-media thickness and vascular elastography in obese adolescents known for hepatic steatosis as diagnosed by liver biopsy

Detailed description

1. Evaluate the feasibility of a larger, open-label, randomized, controlled trial on the effects of polyphenol supplementation: Recruitment, compliance to polyphenol supplementation and the visit roadmaps Duration of the radiological exams and participants' satisfaction and point of view on the experience. Test the relevance of using a food diary. Test the effectiveness of the data collection procedure during the visits. Explore the obstacles encountered while performing the radiological exams and the rate of adverse events (AE). Calculate the sample size of the future randomized clinical study 2. Effects of polyphenols IMT and vascular elastography. Anthropometric measurements, insulin resistance, inflammation, lipid/lipoprotein profile, gut microbiome and liver function 3. Evaluated different imaging modality for steatosis Different imaging modalities will be compared between children

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTEffect of polyphenols on hepatic steatosis and vascular elastography and intima media thicknessMeasurement of effect of polyphenol supplementation vs placebo on hepatic steatosis and vascular elastography and intima media thickness

Timeline

Start date
2021-07-04
Primary completion
2024-12-01
Completion
2024-12-01
First posted
2019-06-21
Last updated
2024-01-23

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03994029. Inclusion in this directory is not an endorsement.